AstraZeneca: all 4,196 studies
Page 22 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- DOuBLED - Doubling Outcomes by Lung Cancer Early DiagnosisCompletedNCT05091437
- FASENRA Regulatory Postmarketing Surveillance in KoreaCompletedNCT05091333
- VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19TerminatedNCT05084755
- Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese ParticipantsCompletedNCT05070312Phase 1
- To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.TerminatedNCT05065463Phase 1
- A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingNCT05057494Phase 3
- Study to Assess the Effect of AZD4831 on the Pharmacokinetics (Drug Behavior in the Body) of MidazolamCompletedNCT05052710Phase 1
- A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 MutationsActive, not recruitingNCT05048797Phase 3
- Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in EnglandCompletedNCT05047822
- A Study of Multiple Doses of ALXN2050 in Healthy AdultsCompletedNCT05047484Phase 1
- A Study of Single-dose ALXN2050 in Healthy AdultsCompletedNCT05047458Phase 1
- Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCCActive, not recruitingNCT05043090Phase 3
- Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White ParticipantsCompletedNCT05033431Phase 1
- A Study of the Cardiac Effects of Danicopan in Healthy AdultsCompletedNCT05016206Phase 1
- Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]AdavosertibTerminatedNCT05008913Phase 1
- Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)CompletedNCT05001698Phase 1
- A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCActive, not recruitingNCT04995523Phase 1/2
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy VolunteersCompletedNCT04994106Phase 1
- Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety StudyCompletedNCT04991805
- Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy ParticipantsCompletedNCT04991571Phase 1
- Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube CancerCompletedNCT04991051
- Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia GravisWithdrawnNCT04982289Phase 2
- Study in Adult and Pediatric Patients With HSCT-TMAWithdrawnNCT04970004
- IBS-C Questionnaire StudyCompletedNCT04968652
- Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Active, not recruitingNCT04964934Phase 3
- Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic LeukemiaCompletedNCT04964908
- HRR Prevalence in LatAm PROSPECT StudyCompletedNCT04962880
- Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse CisplatinActive, not recruitingNCT04960709Phase 3
- A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of AdavosertibTerminatedNCT04959266Phase 1
- A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid TumoursCompletedNCT04958226Phase 1
- Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult ParticipantsCompletedNCT04958135Phase 1
- Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic AnemiaWithdrawnNCT04956276Phase 2
- Study of ALXN2050 in Healthy Adult Participants of Japanese DescentCompletedNCT04952545Phase 1
- A Study to Assess the Pharmacokinetics (Uptake of Drugs by the Body), Safety and Tolerability of AZD4831 in Participants With Severe Renal Impairment and Healthy VolunteersCompletedNCT04949438Phase 1
- A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid TumoursTerminatedNCT04949425Phase 1
- Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy ParticipantsCompletedNCT04944771Phase 1
- Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy ParticipantsCompletedNCT04940559Phase 1
- MEOI and HRQoL in CLL Patients Treated With BTKisCompletedNCT04938141
- Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney DysfunctionCompletedNCT04935294Phase 1
- Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult ParticipantsCompletedNCT04933682Phase 1
- A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid CancerActive, not recruitingNCT04931654Phase 1/2
- Exacerbations and Their Outcomes International (EXACOS International)CompletedNCT04928417
- Study of Subcutaneous and Intravenous ALXN1720 With and Without rHuPH20 in Healthy SubjectsCompletedNCT04920370Phase 1
- A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196CompletedNCT04914936Phase 1
- The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap PatientsCompletedNCT04905420
- A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult ParticipantsCompletedNCT04905043Phase 1
- A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy ParticipantsCompletedNCT04901923Phase 1
- AMAZE™ Asthma Implementation QI StudyCompletedNCT04901260
- A Study to Evaluate the Effect of [14C]Acp-196 (Acalabrutinib) in Healthy Adult ParticipantsCompletedNCT04898101Phase 1
- Phase I Double-blind, Placebo-controlled Study of AZD7442CompletedNCT04896541Phase 1
- Study to Evaluate the Effects of AZD3427 in Patients With Heart FailureWithdrawnNCT04890548Phase 1
- Study of Multiple Doses of Danicopan in Healthy ParticipantsCompletedNCT04889690Phase 1
- Study of a Single Dose of Danicopan in Healthy ParticipantsCompletedNCT04889677Phase 1
- LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)CompletedNCT04889404
- Study of Radiolabeled Danicopan in Healthy Male ParticipantsCompletedNCT04889391Phase 1
- D9319C00001- 1L OC Mono Global RCTActive, not recruitingNCT04884360Phase 3
- A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving DurvalumabCompletedNCT04884269
- Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222TerminatedNCT04877743
- Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus ErythematosusActive, not recruitingNCT04877691Phase 3
- A Study to Evaluate the Effect of an Acidic Formulation of Acalabrutinib (ACP-196), Acidic Beverage, or Grapefruit Juice on the Pharmacokinetics (PK) of ACP-196 Alone and Coadministered With OmeprazoleCompletedNCT04876807Phase 1
- Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationCompletedNCT04872621
- A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung CancerTerminatedNCT04870112Phase 1
- A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult ParticipantsCompletedNCT04867980Phase 1
- A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196CompletedNCT04867941Phase 1
- Forxiga HF General Drug Use-Results StudyCompletedNCT04865406
- Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)Active, not recruitingNCT04862663Phase 3
- Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast CancerCompletedNCT04857619
- A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.CompletedNCT04856007Phase 1
- IMFINZI Study in Patients With Extensive Stage Small Cell Lung CancerCompletedNCT04854590
- REVEAL-CKD: Prevalence and Consequences of Undiagnosed Chronic Kidney DiseaseCompletedNCT04847531
- Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:CompletedNCT04836975
- Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian CancerActive, not recruitingNCT04830709
- AZD9833 China PK StudyCompletedNCT04818632Phase 1
- Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration RateCompletedNCT04814680
- A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)CompletedNCT04808518
- Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung CancerCompletedNCT04808050
- Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low StatusCompletedNCT04807595
- COVID-19 Soliris Expanded Access ProtocolNo longer availableNCT04802083
- Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates CancerCompletedNCT04801186
- Hyperkalaemia Prevalence, Recurrence and Treatment in HaemodialysisCompletedNCT04799067
- Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy VolunteersCompletedNCT04798222Phase 1
- Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)Active, not recruitingNCT04784715Phase 3
- Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy VolunteersCompletedNCT04770428Phase 1
- A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of AsthmaCompletedNCT04769869Phase 1
- Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib CapsuleCompletedNCT04768985Phase 1
- Expanded Access Program for Participants Who Completed Study 13-601 and Continue to Clinically Benefit From CerdulatinibNo longer availableNCT04757259
- Anifrolumab Early Access ProgramNo longer availableNCT04750057
- ALICIA (Acalabrutinib in CLL Therapy)CompletedNCT04746950
- Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung CancerCompletedNCT04742192
- Capivasertib China PK StudyCompletedNCT04742036Phase 1
- Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy VolunteersCompletedNCT04734275Phase 1
- Determination of Prevalence and Features of HRRm mCRPC (ADAM)CompletedNCT04712890
- A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the BodyCompletedNCT04712396Phase 1
- A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseActive, not recruitingNCT04711252Phase 3
- Heart Failure Patients RegistryCompletedNCT04709263
- A Drug Interaction Study of DanicopanCompletedNCT04709094Phase 1
- A Drug Interaction Study of ACH-0145228CompletedNCT04709081Phase 1
- Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male SubjectsCompletedNCT04686591Phase 1
- Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male SubjectsCompletedNCT04675021Phase 1
- Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United KingdomCompletedNCT04667312